[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-04-02-15":3},{"date":4,"filings":5,"has_more":45,"limit":46,"page":47,"total_count":48},"2026-04-02",[6,14,22,26,32,36,41],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"APL Apollo Tubes Ltd","2026-04-02T06:57:47.553000","BSE","Grants 30 Lakh Stock Appreciation Rights (SARs) to Employees","69cdc659280635f81c90f705","APLAPOLLO","• The company has granted **30,00,000 Stock Appreciation Rights (SARs)** to eligible employees under its existing scheme.\n• The exercise price is fixed at **₹1937 per SAR unit**.\n• This grant is a strategic move for employee retention and motivation, linking their compensation to the company's stock performance.\n• **Investor Note:** This action creates a potential for significant future equity dilution when the SARs are exercised.",{"company_name":15,"filing_date":16,"filing_source":17,"headline":18,"id":19,"stock_code":20,"summary_text":21},"Latent View Analytics Limited","2026-04-02T00:47:47.543000","NSE","Invests $3M in a 12-Day-Old Healthcare AI Startup","69cd6f809c7ad595d6dd3f27","LATENTVIEW","*   Latent View's US subsidiary is investing **USD 3 Million** (approx. ₹28 Crores) in a new company, **Healtheon AI INC**.\n*   Healtheon AI is a US-based startup focused on the **Healthcare Revenue Cycle Management (RCM)** sector.\n*   **Key Detail**: The target company was incorporated on March 20, 2026, making it **less than two weeks old** at the time of the investment agreement.\n*   The investment is structured as a **Simple Agreement for Future Equity (SAFE)**, which will convert to stock in a future funding round.\n*   This is a strategic move to strengthen the company's footprint in the **US healthcare AI market**.",{"company_name":15,"filing_date":16,"filing_source":17,"headline":23,"id":24,"stock_code":20,"summary_text":25},"Latent View Invests $3M in US Healthcare AI Startup","69cd6f97f00a0033503f6140","*   Latent View's US subsidiary is investing **$3 million** in cash into **Healtheon AI INC.**, a US-based healthcare AI startup.\n*   The investment is structured as a **SAFE (Simple Agreement for Future Equity)**, providing the right to future shares upon certain trigger events.\n*   The strategic goal is to enter the **Revenue Cycle Management (RCM)** sector for US healthcare providers.\n*   This is a high-risk, venture-style investment as the target company was only incorporated on **March 20, 2026**.",{"company_name":27,"filing_date":28,"filing_source":9,"headline":29,"id":30,"stock_code":20,"summary_text":31},"Latent View Analytics Ltd","2026-04-02T00:42:46.771000","Makes $3M Strategic Investment in US AI Healthcare Startup","69cd6e5145197277283f8949","*   Its US subsidiary is investing **$3 million** in a US-based AI startup, **Healtheon AI INC.**, to enter the US healthcare technology sector.\n*   The investment is structured via SAFE notes, meaning the company will not receive immediate equity or control. Conversion to stock will happen at a future, undetermined valuation.\n*   **High-Risk Profile:** The target company was incorporated just 12 days before the investment agreement and has no financial or operational history, making this a very high-risk, early-stage venture.",{"company_name":27,"filing_date":28,"filing_source":9,"headline":33,"id":34,"stock_code":20,"summary_text":35},"Makes $3M Strategic Investment in US Healthcare AI Startup","69cd6e7a9f91973f4edd17b2","- Latent View's US subsidiary is investing **USD 3 million** in cash into **Healtheon AI INC.**, a US-based startup focused on Revenue Cycle Management (RCM) for healthcare.\n- The investment is structured as a **SAFE (Simple Agreement for Future Equity) note**, which will convert into equity during a future funding round.\n- The strategic goal is to secure a cornerstone stake in the US healthcare RCM sector by investing in an early-stage, high-potential AI company.\n- **Key Risk:** The target company, Healtheon AI, was incorporated on **March 20, 2026**, just 12 days before the investment agreement. It has **no operational or financial history**, making this a high-risk, seed-stage investment.",{"company_name":15,"filing_date":37,"filing_source":17,"headline":38,"id":39,"stock_code":20,"summary_text":40},"2026-04-02T00:37:47.626000","Subsidiary Invests $3M in AI Healthcare Firm","69cd6d4c45197277283f8942","• LatentView Analytics Corporation, a wholly-owned subsidiary, is making a strategic investment in Healtheon AI INC.\n• The total investment amount is USD 3,000,000, paid entirely in cash.\n• The transaction is structured via a Simple Agreement for Future Equity (SAFE) Notes.\n• The agreement was executed on April 01, 2026, with completion expected on or before April 07, 2026.",{"company_name":15,"filing_date":37,"filing_source":17,"headline":42,"id":43,"stock_code":20,"summary_text":44},"Latent View Bets $3M on a 12-Day-Old AI Healthcare Startup","69cd6d4c3b41300152f3aee6","*   Latent View's US subsidiary is investing $3 million in a new company, M\u002Fs. Healtheon AI INC.\n*   The investment targets the US healthcare Revenue Cycle Management (RCM) sector, aiming to secure a stake in a high-potential AI framework.\n*   The deal is structured as a SAFE Note, which will convert to equity in a future financing round. Latent View gains no immediate shares or control.\n*   This is a high-risk, venture-style investment, as the target company was incorporated just 12 days before the agreement was signed.",false,100,15,1407]